A new study from Mass Eye and Ear suggests that people taking semaglutide, a drug sold as Ozempic and Wegovy, may have a ...

More than one-third of people who helped develop the 2023 guidelines for treating children with obesity had undisclosed ...

Companies are selling personalized compounded drugs that combine weight loss and erectile dysfunction treatments, but is this safe? No one can say because it’s all “personalized” compounded drugs ...

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

Significant periods of weight regain were observed at eight, 12, and 20 weeks after stopping the anti-obesity medications. The analysis revealed that the weight rebound typically continued for an ...

According to a recent study, nearly three in four Americans are overweight. Worse, this report predicts that for decades to ...

In just a few years, weight-loss drugs like Ozempic and Wegovy have become a global sensation. They promise to do something ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

With Gov. Patrick Morrisey’s first special session of 2025 likely to be focused on health care costs for public employees, ...